- Tuesday, February 10, 2026
- India +91 7982732466
- U.S +1 217 953 4020
- Info@Shingetsuresearch.com
Global In-vivo Toxicology Market By Product and Services (Consumables, Assays, Equipment, Software, and Services), By Testing Type (Chronic Toxicity Testing, Sub-chronic Toxicity Testing, Sub-acute Toxicity Testing, and Acute Toxicity Testing), By Toxicity Endpoints (Immunotoxicity, Systemic Toxicity, Carcinogenicity, Genotoxicity, Developmental & Reproductive Toxicity, and Other Toxicity Endpoints), and By Region (North America, Europe, Asia Pacific, South America, and the Middle East & Africa)-Global Forecast to 2027.
Description
Global In-vivo Toxicology Market Overview:
The In-vivo toxicology market is estimated to reach USD 8.12 billion by 2030, growing at a CAGR of 5.70% during the forecast period 2020-2027. It was valued at USD 4.98 billion in 2022. Toxicology is a multidisciplinary field of science that helps study adverse effects in living organisms and the environment due to chemicals, substances, or situations. It involves observing and reporting symptoms that arise following exposure to toxic substances. It includes detecting, identifying, and quantifying hazards ensuing from human exposure to chemicals, public health aspects of toxic agents in the environment, and testing novel pharmaceutical products.Global In-vivo Toxicology Market Insights
The significant factors are the growing demand for toxicology testing during drug development at an early stage and increasing R&D investments. Additionally, the ever-increasing advances in animal models and compulsory animal testing regulations will spur the in-vivo toxicology industry in the future periods. Furthermore, the growing public-private funding for pharmaceutical research activities and rising concerns for drug safety are expected to witness remarkable growth of in-vivo toxicology. The increasing demand for novel therapeutics and the rising number of clinical trials are expected to propel the demand for in-vivo toxicology over the coming years. Moreover, the growth in demand for personalized medicine and strict government standards towards drug safety positively impacts the market for in-vivo toxicology in the healthcare industry. Furthermore, the rapidly expanding demand for new drugs, rise in the extensive R&D activities at the academic and industrial level, and increasing extent of biomedical applications are fueling the need for the in-vivo toxicology market. The growing applications of in-vivo toxicology in oncology research and the development of novel vaccines will bolster the growth of the global in-vivo toxicology market share. Additionally, the ever-increasing geriatric population and growing healthcare demands in the developing world propelling the development of the in-vivo toxicology market across the globe.Growth Driver
Toxicology screening is vital for the development of drugs. Pharmaceutical industries are rapidly adopting animal models to predict human toxicity. Animal models are good predictors of drug safety in humans as animal tests can genuinely identify a safe chemical as toxic and help find potentially beneficial drugs for human use. Also, the cost of animal models in comparison to in-vitro toxicology is low and consumes less time. In addition, animal models are used in novel and therapeutic agents and permit faster evaluation of vaccines. However, the growing ethical concerns over animal models and adaptation of alternative methods can be a restraint to the growth of the global in-vivo toxicology market.Product Segmental Analysis
Based on the product, the global in-vivo toxicology market is segregated into consumables and instruments. Furthermore, the consumables are segmented into divided into reagents & kits and animal models, including mice models, rat models, and other animal models. The consumables segment is estimated to the highest growth over the analysis timeframe due to the growth in the development of genetically modified animals, increasing pharmaceutical research for developing new drugs, and rising extensive funding to create new transgenic animal models. The instruments will grow significantly due to the rising in-vivo toxicology systems adoption, rise in the utilization of in-vivo technology, and rising concerns towards drug safety.Testing Type Segmental Analysis
Based on the testing type, the global in-vivo toxicology market is categorized into chronic toxicity testing, sub-chronic toxicity testing, sub-acute toxicity testing, and acute toxicity testing. The chronic toxicity testing segment is held for a significant market share in 2021 and will gain maximum market revenue by 2030. It is attributable to the increasing R&D activities, and rising research focused on drugs used for long-duration therapies, including anti-cancer, anti-hypertensives, anti-arthritis, and anti-convulsive. The acute toxicity testing segment is poised to witness significant growth over the forecast period. It involves testing for adverse effects arising from single or multiple exposures within a short time frame and highly applicable for animal models.Toxicity Endpoint Segmental Analysis
Based on the toxicity endpoint, the global in-vivo toxicology market is classified into immunotoxicity, systemic toxicity, carcinogenicity, genotoxicity, developmental & reproductive toxicity, and other toxicity endpoints. The immunotoxicity is expected to be the highest revenue share for in-vivo toxicology during the forecast period. The segment’s revenue is primarily attributed to the growing epidemiologic research and increasing demand for biologics and biosimilar development. The carcinogenicity will witness a lucrative growth rate in the estimated period due to rising studies in animal toxicology, rising prevalence of cancer, and increasing demand for anti-cancer drugs.Region Segmental Analysis
The global in-vivo toxicology market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa by geography. North America is estimated to project considerable growth over 2022-2030. It is owing to advents in technology, the presence of leading industry players offering preclinical testing services, and increasing healthcare expenditure. The Asia Pacific will capture a significant share of the in-vivo toxicology market by 2030. Due to the increasing number of CROs offering in-vivo toxicology services, continually improving healthcare infrastructure in the region, and mounting health care expenditures in emerging countries such as India and China.Competitor Analysis
Companies such as Danaher, Thermo Fisher Scientific, Charles River, Covance, The Jackson Laboratory, Taconic Biosciences Inc, Eurofins Scientific, Envigoand Dynamic Systems Inc are the key players in the global in-vivo toxicology market.Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global in-vivo toxicology tests manufacturing firm
- Research organizations and consulting companies
- Organizations, associations, and alliances related to in-vivo toxicology
- Regulatory bodies
- Suppliers
- Retailers
The objective of the research
- Market modeling starts with identifying a target market where historical data exists. A Market can include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our client to have deep dive into the market.
- Product analysis involves examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
- Market Trend and Economic Factors Analysis helps assess potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a significant effect on the target market.
- Market Segmental Analysis defines an in-depth scenario of the target market by grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics.
- The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs, wants, and cultural characteristics that can specifically target.
Market Modelling
By Product & Services- Consumables
- Reagents and Kits
- Animal Models
- Instrument’s
- Chronic Toxicity Testing
- Sub-chronic Toxicity Testing
- Sub-acute Toxicity Testing
- Acute Toxicity Testing
- Immunotoxicity
- Systemic Toxicity
- Carcinogenicity
- Genotoxicity
- Developmental and Reproductive Toxicity
- Other Toxicity Endpoints
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
More Related Reports:
Southeast Asia Water Purifier Market
Pharmaceutical Vial Fillers Market
Healthcare Fraud Analytics Market
Video Streaming Software Market
Table Of Contents
Global In-vivo Toxicology Market
Report Content
- Research Strategic Development
- Market Modelling
- Product Analysis
- Market Trend and Economic Factors Analysis
- Market Segmental Analysis
- Geographical Mapping
- Country Wise Segregation
- Research Methodology
- Identification of Target Market
- Data Acquisition
- Refining of Data/ Data Transformations
- Data Validation through Primary Techniques
- Exploratory Data Analysis
- Graphical Techniques/Analysis
- Quantitative Techniques/Analysis
- Visual Result/Presentation
- Executive Summary
- Market Insights
- Supply Chain Analysis
- Economic Factor Analysis
- Drivers
- Trends
- Opportunities
- Challenges
- Technological Landscape
- Competitors & Product Analysis
- Regulatory Framework
- Company market share analysis, 2019
- Porter’s Five forces analysis
- New Investment Analysis
- PESTEL Analysis
- Global In-vivo Toxicology Market Overview
- Market Size & Forecast,2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- Market Share & Forecast, 2016-2027
- By Product & Services
- Consumables
- Reagents and Kits
- Animal Models
- Instruments
- By Testing Type
- Chronic Toxicity Testing
- Sub-chronic Toxicity Testing
- Sub-acute Toxicity Testing
- Acute Toxicity Testing
- By Toxicity Endpoints
- Immunotoxicity
- Systemic Toxicity
- Carcinogenicity
- Genotoxicity
- Developmental and Reproductive Toxicity
- Other Toxicity Endpoints
- By Region
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
- By Product & Services
- Market Size & Forecast,2016-2027
- North America In-vivo Toxicology Market Overview
- North America In-vivo Toxicology Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- North America In-vivo Toxicology Market Share & Forecast,2016-2027
- By Product & Services
- Consumables
- Reagents and Kits
- Animal Models
- Instruments
- By Testing Type
- Chronic Toxicity Testing
- Sub-chronic Toxicity Testing
- Sub-acute Toxicity Testing
- Acute Toxicity Testing
- By Toxicity Endpoints
- Immunotoxicity
- Systemic Toxicity
- Carcinogenicity
- Genotoxicity
- Developmental and Reproductive Toxicity
- Other Toxicity Endpoints
- By Country
- US
- Canada
- Mexico
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on North America In-vivo Toxicology Market
- By Product & Services
- North America In-vivo Toxicology Market Size & Forecast, 2016-2027
- Europe In-vivo Toxicology Market Overview
- Europe In-vivo Toxicology Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- Europe In-vivo Toxicology Market Share & Forecast,2016-2027
- By Product & Services
- Consumables
- Reagents and Kits
- Animal Models
- Instruments
- By Testing Type
- Chronic Toxicity Testing
- Sub-chronic Toxicity Testing
- Sub-acute Toxicity Testing
- Acute Toxicity Testing
- By Toxicity Endpoints
- Immunotoxicity
- Systemic Toxicity
- Carcinogenicity
- Genotoxicity
- Developmental and Reproductive Toxicity
- Other Toxicity Endpoints
- By Country
- Germany
- UK
- France
- Italy
- Rest of Europe
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on Europe In-vivo Toxicology Market
- By Product & Services
- Europe In-vivo Toxicology Market Size & Forecast, 2016-2027
- Asia Pacific In-vivo Toxicology Market Overview
- Asia Pacific In-vivo Toxicology Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- Asia Pacific In-vivo Toxicology Market Share & Forecast, 2016-2027
- By Product & Services
- Consumables
- Reagents and Kits
- Animal Models
- Instruments
- By Testing Type
- Chronic Toxicity Testing
- Sub-chronic Toxicity Testing
- Sub-acute Toxicity Testing
- Acute Toxicity Testing
- By Toxicity Endpoints
- Immunotoxicity
- Systemic Toxicity
- Carcinogenicity
- Genotoxicity
- Developmental and Reproductive Toxicity
- Other Toxicity Endpoints
- By Country
- China
- India
- Japan
- Australia
- Rest of Asia Pacific
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on Asia Pacific In-vivo Toxicology Market
- By Product & Services
- Asia Pacific In-vivo Toxicology Market Size & Forecast, 2016-2027
- South America In-vivo Toxicology Market Overview
- South America In-vivo Toxicology Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- South America In-vivo Toxicology Market Share & Forecast,2016-2027
- By Product & Services
- Consumables
- Reagents and Kits
- Animal Models
- Instruments
- By Testing Type
- Chronic Toxicity Testing
- Sub-chronic Toxicity Testing
- Sub-acute Toxicity Testing
- Acute Toxicity Testing
- By Toxicity Endpoints
- Immunotoxicity
- Systemic Toxicity
- Carcinogenicity
- Genotoxicity
- Developmental and Reproductive Toxicity
- Other Toxicity Endpoints
- By Country
- Brazil
- Argentina
- Rest of South America
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on South America In-vivo Toxicology Market
- By Product & Services
- South America In-vivo Toxicology Market Size & Forecast, 2016-2027
- Middle East & Africa In-vivo Toxicology Market Overview
- Middle East & Africa In-vivo Toxicology Market Size & Forecast, 2016-2027
- Demand
- By Value (USD Million)
- Consumption
- Demand
- Middle East & Africa In-vivo Toxicology Market Share & Forecast, 2016-2027
- By Product & Services
- Consumables
- Reagents and Kits
- Animal Models
- Instruments
- By Testing Type
- Chronic Toxicity Testing
- Sub-chronic Toxicity Testing
- Sub-acute Toxicity Testing
- Acute Toxicity Testing
- By Toxicity Endpoints
- Immunotoxicity
- Systemic Toxicity
- Carcinogenicity
- Genotoxicity
- Developmental and Reproductive Toxicity
- Other Toxicity Endpoints
- By Country
- Saudi Arabia
- UAE
- South Africa
- Rest of Middle East & Africa
- Price-Point Analysis
- Manufacturer & Distributor List (Top 5)
- Company Market Share (Top 3-5)
- Economic Impact Study on Middle East & Africa In-vivo Toxicology Market
- By Product & Services
- Middle East & Africa In-vivo Toxicology Market Size & Forecast, 2016-2027
- Competitor Analysis
- Company Description
- Financial Analysis
- Key Products
- Key Management Personnel
- Contact Address
- SWOT Analysis
- Company Profile
- Danaher
- Thermo Fisher Scientific
- Charles River
- Covance
- The Jackson laboratory
- Taconic Biosciences Inc
- Eurofins Scientific
- Envigoand Dynamic Systems Inc
Methodology
Request Sample
Frequently Asked Questions (FAQ)
The In-vivo toxicology market is estimated to reach USD 8.12 billion by 2030, growing at a CAGR of 5.70% during the forecast period 2020-2027. It was valued at USD 4.98 billion in 2022.
the growing public-private funding for pharmaceutical research activities and rising concerns for drug safety are expected to witness remarkable growth of in-vivo toxicology.
Companies such as Danaher, Thermo Fisher Scientific, Charles River, Covance, The Jackson Laboratory, Taconic Biosciences Inc, Eurofins Scientific, Envigoand Dynamic Systems Inc are the key players in the global in-vivo toxicology market.
The consumables segment is estimated to have the highest growth.
